SCHEMBL3362984

SCHEMBL3362984

CC(C)N1CCCN(c2cncc(-c3cc(C=C4SC(=O)NC4=O)ccc3F)n2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIPK2 Q9H2X6 1/20 0.38
PIM1 P11309 10/20 0.37
PIM2 Q9P1W9 8/20 0.37
GPR119 Q8TDV5 1/20 0.37
MPL P40238 1/20 0.36
MTOR P42345 3/20 0.36
CISD1 Q9NZ45 3/20 0.36
GSK3B P49841 2/20 0.36
MAOA P21397 1/20 0.36
IGF1R P08069 2/20 0.35
PIK3CD O00329 2/20 0.35
CSNK2A2 P19784 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35
PIK3CG P48736 2/20 0.35
CLK1 P49759 2/20 0.35
DYRK1A Q13627 2/20 0.35
GAK O14976 1/20 0.35
RPS6KA4 O75676 1/20 0.35
STK10 O94804 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12990271 1.00 HIPK2 (0.38) HIPK2PIM1PIM2GPR119MPL
SCHEMBL3362980 1.00 HIPK2 (0.38) HIPK2PIM1PIM2GPR119MPL
SCHEMBL3362473 0.93 PTP4A3 (0.42) PIM1PIM2MTORPIK3CDCSNK2A2
SCHEMBL3362468 0.93 PTP4A3 (0.42) PIM1PIM2MTORPIK3CDCSNK2A2
SCHEMBL12990361 0.93 PTP4A3 (0.42) PIM1PIM2MTORPIK3CDCSNK2A2
SCHEMBL3363323 0.89 PIM2 (0.44) HIPK2PIM1PIM2GPR119MPL
SCHEMBL12990427 0.89 PIM2 (0.44) HIPK2PIM1PIM2GPR119MPL
SCHEMBL3363320 0.89 PIM2 (0.44) HIPK2PIM1PIM2GPR119MPL
SCHEMBL12990270 0.87 PIM1 (0.45) HIPK2PIM1PIM2GPR119MPL
SCHEMBL3364454 0.87 PIM1 (0.45) HIPK2PIM1PIM2GPR119MPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331315-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS SENHWA BIOSCIENCES, INC. (TW) 2010-12-30 US disclosed
WO-2010148351-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS CYLENE PHARMACEUTICALS, INC. (US) 2010-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331315-A1 RHODANINES AND RELATED HETEROCYCLES AS KINASE INHIBITORS PIM2, PIM1, CDK2 HIPK2 77/4885PIM1 2/4885PIM2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.